Petros Pharmaceuticals Inc - PTPI Net Margin

Graphic logo of Petros Pharmaceuticals Inc (PTPI)

The net margin structure demonstrates the impact of operating exclusively in the US market, where the value of 0.00 describes the current profitability level. Petros Pharmaceuticals (PTPI) generates revenue based on the sale of Stendra and IT services for men. Efficiency is maintained by outsourcing production and logistics to third-party contractors, which optimizes the company's internal costs.

Petros Pharmaceuticals (PTPI) Net Margin: for the period 07/04/2022 - 06/28/2025

Petros Pharma (PTPI) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
General company analysis:Petros Pharmaceuticals, Inc. - PTPI
Finished products of Petros

Sales margin determines the share of net profit in every dollar of revenue, reflecting the ultimate efficiency of cost management. By analyzing the current sales margin level, an investor assesses the business's ability to generate real cash flow. The metric is calculated as the ratio of net profit to total sales. For Petros Pharmaceuticals (PTPI), this metric confirms the monetization of R&D developments in drug bioavailability. High profitability here indicates the successful implementation of digital IT platforms into therapy.

Who Petros Pharmaceuticals competes with

HLN: Net Sales Margin|Net Return on Sales KVUE|Net Margin veronapharma.com|Net Return on Sales MENS (Jyong Biotech Corp)|Net Margin Ligand (LGND)|Net Sales Margin amneal.com (AMRX)|Net Sales Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Net Margin|Liquidia Inc. - Net Sales Margin|Net Profitability Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Net Margin|Net Return on Sales MNKD|Net Margin Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Company Sales Margin|Net Sales Margin SPRY|TBPH - Net Margin|Aquestive Pharma - Return on Sales by Net Profit|Net Sales Margin scpharmaceuticals.com SCPH|Tectonic - Net Sales Margin|TNXP - Net Sales Margin|SXTC: Net Sales Margin|Eupraxia Pharma - Net Profit Rate|BHST (bioharvest.com) - Net Sales Margin|Net Return on Sales EXOZ (invizyne.com)|Net Sales Margin ORMP|Company Sales Margin Entera Bio|Net Sales Margin HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Net Margin|Cumberland Corp - Net Sales Margin|QNTM - Net Sales Margin|FibroGen, Inc. (FGEN) - Net Margin|TELO: Company Net Profitability|RANI (Rani Therapeutics Inc) - Net Sales Margin|Net Margin synergychc.com SNYR|Net Margin Rallybio Corp. (RLYB)|LEXX - Net Margin|Net Sales Margin PULM (pulmatrix.com)|Company Net Profitability PTHL (Pheton)|APM - Net Margin|Company Sales Margin Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Net Margin|TNF Pharma (TNFA) - Net Sales Margin|YCBD (cbdmd.com) - Net Sales Margin|Return on Sales by Net Profit PainReform (PRFX)|Net Margin Altamira Therapeutics (CYTO)|Company Sales Margin Lipella Pharma|Optinose - Return on Sales by Net Profit|Company Sales Margin pieris.com (PIRS)|PROC - Net Margin|Qilian International Holding (QLI) - Return on Sales by Net Profit|SLRN: Net Sales Margin|Return on Sales by Net Profit TFF Pharma